 |
|
|
|
 |
|
|
| Article 1 to 10 out of 10 concerning Caliper Life Sciences, Inc.
|
-
Caliper Creates Specialized ACES Team to Deliver Customized Technology Solutions
(28 Jan 2008)
Initiative to Deliver Best-In-Class Solutions for Laboratory Automation
Caliper Life Sciences, Inc. announced the formation of its Automation, Consulting, Engineering & Services (ACES) team to create customized, multi-vendor automation solutions. The ACES team includes engineers and scientists with deep experience in ...
-
Caliper Life Sciences Launches Comprehensive Drug Discovery and Development Services Business
(23 Jan 2007)
Caliper Life Sciences, Inc. unveiled Caliper Discovery Alliances & Services (CDAS), the newly-formed services organization created from the integration of NovaScreen Biosciences, a provider of in vitro discovery services, and Xenogen Biosciences, a ...
-
Xenogen Biosciences Announces Target Validation Collaboration Agreement with Schering-Plough
(21 Aug 2006)
Xenogen Biosciences, acquired on August 9, 2006, by Caliper Life Sciences, Inc. , announced a target validation collaboration with Schering-Plough Corporation, under which Xenogen Biosciences will utilize its proprietary Serial Phenotyping ...
-
Caliper Life Sciences and Xenogen Schedule Stockholder Meetings to Approve Merger
(18 Jul 2006)
Caliper Life Sciences, Inc. and Xenogen Corporation announced that the S-4 registration statement-joint proxy statement for their previously announced pending merger was declared effective by the United States Securities and Exchange Commission on ...
-
NovaScreen Receives Wyeth Contract for High Throughput Screen
(28 Jun 2006)
NovaScreen Biosciences Corporation, a Caliper Life Sciences Company, announced that Wyeth Pharmaceuticals, a division of Wyeth, has selected NovaScreen to conduct a high-throughput screening (HTS) campaign. As a result, NovaScreen will screen ...
-
Agilent Technologies licenses Caliper's LabChip® technology for diagnostic applications
(14 Jul 2005)
Caliper Life Sciences Inc. and Agilent Technologies Inc. today announced an agreement granting Agilent a non-exclusive license to use a majority of Caliper's microfluidics patent estate for the development of clinical diagnostic applications on ...
-
Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
(27 Apr 2005)
Caliper Life Sciences, Inc. and Affymetrix, Inc. announced that Caliper has issued Affymetrix a non-exclusive license to use a portion of Caliper's microfluidics patent estate with Affymetrix' GeneChip(R) microarray technologies. The license extends ...
-
Agilent Technologies announces more than one million bioanalyzer chips sold
(06 Oct 2004)
Agilent Technologies Inc. announced that it has sold more than one million LabChip(r) chips -- small, analytical devices used with the Agilent 2100 bioanalyzer to perform fast, automated analysis of DNA, RNA, proteins and cells. These chips are ...
-
Caliper Life Sciences and Promega Introduce Validated Automation Protocols for Caliper's Sciclone Liquid Handling Workstations
(25 Aug 2004)
Caliper Life Sciences, Inc., in collaboration with Promega Corporation, announced that it has integrated all of the Promega SV 96 Sample Preparation methods into its Caliper Sciclone ALH 3000 Workstation, including kits for genomic DNA purification, ...
-
Caliper Life Sciences Acquires Technology for New Approach
(07 May 2004)
to Cell-Based Drug Discovery from Amphora Discovery
Hopkinton and Research Triangle Park. Caliper Life Sciences, Inc. and Amphora Discovery Corp. announced that they have entered into a definitive agreement for Caliper to acquire certain technology developed by Amphora for cell-based screening ...
|
|
|
|
|
Top
